BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 10411939)

  • 1. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
    Rekhtman N; Radparvar F; Evans T; Skoultchi AI
    Genes Dev; 1999 Jun; 13(11):1398-411. PubMed ID: 10364157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
    Rekhtman N; Choe KS; Matushansky I; Murray S; Stopka T; Skoultchi AI
    Mol Cell Biol; 2003 Nov; 23(21):7460-74. PubMed ID: 14559995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
    Zhang P; Zhang X; Iwama A; Yu C; Smith KA; Mueller BU; Narravula S; Torbett BE; Orkin SH; Tenen DG
    Blood; 2000 Oct; 96(8):2641-8. PubMed ID: 11023493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
    Nerlov C; Querfurth E; Kulessa H; Graf T
    Blood; 2000 Apr; 95(8):2543-51. PubMed ID: 10753833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding.
    Eisbacher M; Holmes ML; Newton A; Hogg PJ; Khachigian LM; Crossley M; Chong BH
    Mol Cell Biol; 2003 May; 23(10):3427-41. PubMed ID: 12724402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.
    Nerlov C; Graf T
    Genes Dev; 1998 Aug; 12(15):2403-12. PubMed ID: 9694804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.
    Matsumura I; Kawasaki A; Tanaka H; Sonoyama J; Ezoe S; Minegishi N; Nakajima K; Yamamoto M; Kanakura Y
    Blood; 2000 Oct; 96(7):2440-50. PubMed ID: 11001896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
    Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
    Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.
    Burda P; Curik N; Kokavec J; Basova P; Mikulenkova D; Skoultchi AI; Zavadil J; Stopka T
    Mol Cancer Res; 2009 Oct; 7(10):1693-703. PubMed ID: 19825991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
    Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
    Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation.
    Yamaguchi Y; Zon LI; Ackerman SJ; Yamamoto M; Suda T
    Blood; 1998 Jan; 91(2):450-7. PubMed ID: 9427697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
    Murrell AM; Green AR
    Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
    Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
    Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.
    Elagib KE; Xiao M; Hussaini IM; Delehanty LL; Palmer LA; Racke FK; Birrer MJ; Ganapathy-Kanniappan S; McDevitt MA; Goldfarb AN
    Mol Cell Biol; 2004 Sep; 24(17):7779-94. PubMed ID: 15314183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
    Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
    Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-1 forms distinct activating and repressive complexes in erythroid cells.
    Rodriguez P; Bonte E; Krijgsveld J; Kolodziej KE; Guyot B; Heck AJ; Vyas P; de Boer E; Grosveld F; Strouboulis J
    EMBO J; 2005 Jul; 24(13):2354-66. PubMed ID: 15920471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.